Ventilator Associated Pneumonia a challenge in intensive care unit acquired infection

Authors

  • Munmundas Sarkar Associate professor, Department of Microbiology & Deputy Secretary, Govt of west Bengal, Dept of Health & FW
  • Hirak Jyoti Raj Assistant Professor, Dept. of Microbiology, Institute of post-graduate Medical education and research, 244, ajc bose road, Kolkata-700020
  • Tapan kumar Ghosh Director, RBTC, B.S. Medical College, Bankura

DOI:

https://doi.org/10.3329/bjms.v15i4.24962

Keywords:

Ventilator-Associated Pneumonia, drug resistance, Staphylococcus aureus

Abstract

Background: Ventilator-Associated Pneumonia (VAP) is one of the frequent intensive-care-unit (ICU)-acquired infection. The aetiology of VAP varies with patients profiles and ICU settings. Due to the increasing incidence of multidrug-resistant organisms in ICUs, early and correct diagnosis of VAP is an urgent challenge for an optimal antibiotic treatment. The aim of the study was to assess the incidence of VAP in different patients by various organisms to create a database of the causative agents of VAP, their drug resistance profile in that area.

Methodology: A prospective study was done over a period of 12 months in a rural tertiary care hospital enrolling patients undergoing mechanical ventilation (MV) for >48 h. Samples were collected from patients with suspected VAP, cultures were performed on all samples. VAP was diagnosed by the growth of significant pathogens. Combination disk method, EDTA disk synergy (EDS) test and cefoxitin double disc synergy test were performed for the detection of different patterns of drug resistance.

Results: Culture positive cases were 52.29% of total. Acinetobacter spp, Klebsiella pneumoniae and Staphylococcus aureus were most frequent pathogen in early-onset VAP, while Pseudomonas spp. and Acinetobacter spp. dominated the list of pathogens responsible for lateonset VAP. Prior antibiotic therapy and hospitalization of five days or more were independent risk factors for VAP by MDR pathogens.

Conclusions: This study highlighted high incidence of VAP in our setup. Production of ESBL, AmpC beta-lactamases and metallo beta-lactamases were responsible for the multi-drug resistance of the pathogens causing VAP, implicating the injudicious use of antimicrobial therapy. Combined approaches of rotational antibiotic therapy and education programs might be beneficial to fight against these MDR pathogens to decrease the incidence of VAP.

Bangladesh Journal of Medical Science Vol.15(4) 2016 p.588-595

Downloads

Download data is not yet available.
Abstract
8
PDF
14

Downloads

Additional Files

Published

2016-12-18

How to Cite

Sarkar, M., Raj, H. J., & Ghosh, T. kumar. (2016). Ventilator Associated Pneumonia a challenge in intensive care unit acquired infection. Bangladesh Journal of Medical Science, 15(4), 588–595. https://doi.org/10.3329/bjms.v15i4.24962

Issue

Vol. 15 No. 4 (2016)

Section

Original Articles

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.